| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹30.80 | ₹61.70 | ₹68.59 | ₹77.87 |
| Other Income | ₹0.27 | ₹0.44 | ₹0.62 | ₹0.54 |
| Total Revenue | ₹31.07 | ₹62.14 | ₹69.21 | ₹78.41 |
| Total Expenses | ₹44.81 | ₹62.09 | ₹67.33 | ₹84.34 |
| Profit Before Tax | -₹26.00 | ₹0.05 | ₹1.99 | -₹6.00 |
| Tax | -₹0.02 | -₹0.80 | -₹0.04 | -₹0.47 |
| Profit After Tax | -₹25.98 | ₹0.85 | ₹2.03 | -₹5.53 |
| EPS - Basic | -₹10.39 | ₹0.34 | ₹0.81 | -₹2.21 |
| EPS - Diluted | -₹10.39 | ₹0.34 | ₹0.81 | -₹2.21 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹25.98 | ₹0.85 | ₹2.03 | -₹5.53 |
| Income before WC changes | -₹19.21 | ₹10.98 | ₹12.12 | ₹4.13 |
| Change in Assets | ₹18.42 | -₹4.80 | -₹2.40 | -₹15.18 |
| Change in Liabilities | ₹21.54 | ₹5.59 | -₹4.88 | ₹19.62 |
| Change in WC | ₹39.96 | ₹0.78 | -₹7.28 | ₹4.45 |
| Cash flow from Operations | ₹20.75 | ₹11.76 | ₹4.84 | ₹8.58 |
| Cash flow from Investing | -₹0.25 | -₹1.46 | ₹2.55 | ₹1.40 |
| Cash flow from Financing | -₹3.92 | -₹10.44 | -₹7.41 | -₹10.96 |
| Total Cash Flow | ₹16.58 | -₹0.14 | -₹0.01 | -₹0.98 |
| Cash (Start of the year) | ₹1.19 | ₹1.33 | ₹1.34 | ₹2.32 |
| Cash (End of the year) | ₹17.77 | ₹1.19 | ₹1.33 | ₹1.34 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹85.22 | ₹89.43 | ₹86.24 | ₹86.98 |
| Current Assets | ₹70.84 | ₹71.74 | ₹74.24 | ₹78.96 |
| Total Assets | ₹156.06 | ₹161.18 | ₹160.48 | ₹165.94 |
| Current Liabilities | ₹114.49 | ₹66.11 | ₹65.27 | ₹69.45 |
| Net Current Asset | -₹43.65 | ₹5.63 | ₹8.98 | ₹9.51 |
| Non-Current Liabilities | ₹9.21 | ₹36.73 | ₹37.73 | ₹41.03 |
| Equity Capital | ₹32.36 | ₹58.33 | ₹57.49 | ₹55.46 |
| Total Equity & Liabilities | ₹156.06 | ₹161.18 | ₹160.48 | ₹165.94 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹30.88 | ₹58.75 | ₹67.56 | ₹64.10 |
| Other Income | ₹0.25 | ₹1.06 | ₹0.54 | ₹0.47 |
| Total Revenue | ₹31.14 | ₹59.81 | ₹68.10 | ₹64.57 |
| Total Expenses | ₹38.56 | ₹59.80 | ₹66.93 | ₹66.88 |
| Profit Before Tax | -₹19.67 | ₹0.01 | ₹1.20 | -₹2.38 |
| Tax | -₹0.02 | -₹0.38 | ₹0.12 | -₹0.10 |
| Profit After Tax | -₹19.66 | ₹0.39 | ₹1.08 | -₹2.28 |
| EPS - Basic | -₹7.86 | ₹0.16 | ₹0.43 | -₹0.96 |
| EPS - Diluted | -₹7.86 | ₹0.16 | ₹0.43 | -₹0.96 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹19.66 | ₹0.39 | ₹1.08 | -₹2.28 |
| Income before WC changes | -₹15.54 | ₹8.21 | ₹8.68 | ₹4.82 |
| Change in Assets | ₹15.76 | -₹5.03 | -₹6.75 | -₹10.61 |
| Change in Liabilities | ₹20.43 | ₹3.76 | ₹0.22 | ₹11.30 |
| Change in WC | ₹36.19 | -₹1.26 | -₹6.53 | ₹0.69 |
| Cash flow from Operations | ₹20.66 | ₹6.94 | ₹2.15 | ₹5.51 |
| Cash flow from Investing | -₹0.27 | -₹0.93 | -₹1.08 | -₹3.85 |
| Cash flow from Financing | -₹3.46 | -₹6.41 | -₹1.17 | -₹2.65 |
| Total Cash Flow | ₹16.93 | -₹0.40 | -₹0.10 | -₹0.99 |
| Cash (Start of the year) | ₹0.73 | ₹1.13 | ₹1.22 | ₹2.21 |
| Cash (End of the year) | ₹17.66 | ₹0.73 | ₹1.13 | ₹1.22 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹75.70 | ₹78.13 | ₹72.39 | ₹70.99 |
| Current Assets | ₹66.97 | ₹64.76 | ₹68.24 | ₹68.79 |
| Total Assets | ₹142.68 | ₹142.89 | ₹140.63 | ₹139.78 |
| Current Liabilities | ₹97.59 | ₹56.16 | ₹57.99 | ₹56.87 |
| Net Current Asset | -₹30.62 | ₹8.60 | ₹10.25 | ₹11.92 |
| Non-Current Liabilities | ₹2.93 | ₹24.92 | ₹21.22 | ₹22.57 |
| Equity Capital | ₹42.16 | ₹61.81 | ₹61.42 | ₹60.35 |
| Total Equity & Liabilities | ₹142.68 | ₹142.89 | ₹140.63 | ₹139.78 |
Cian Healthcare Limited is an India-based company, which is engaged in manufacturing of Pharmaceuticals, OTCs, Supplements and Veterinary products. The Company is engaged in manufacturing multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets. Its portfolio comprises gynaecology, haematinic, cardio- diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrient products. It is also engaged in the business of manufacturing cosmetic products. The Company's services include pharma visual aid (book or spiral) design and printing, pharma literature design and printing, pharma monographs/ reference folders, LBL’s/ reminder cards design, pharma poster design, pharmaceutical carton/ catch cover designing, corporate identity design, advertising design, product information leaflet, and brand communication. The Company's subsidiary includes Dr. Smith Biotech Private Limited.
Cian Healthcare Limited share price is ₹8.26 as on 10 Apr, 2026, 09:46 IST.
The Mutual Fund Shareholding in Cian Healthcare Limited was 0.00% at the end of Mar 2026.
The 52-week high and low of Cian Healthcare Limited share is ₹8.26 and ₹3.11 as of 10 Apr, 2026.
The market capitalisation of Cian Healthcare Limited is ₹0.00 Crores as on 10 Apr, 2026.
The stock symbol of Cian Healthcare Limited is 542678 on the BSE, and the ISIN is INE05BN01027.
To buy Cian Healthcare Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Cian Healthcare Limited shares closed yesterday at ₹8.26 on BSE
No, shares of Cian Healthcare Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Cian Healthcare Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.